Choosing the right dose of mew immunossuppressive drugs for new populations: Importance of pharmacokinetic studies

被引：10

作者：

Felipe, CR ^{[1
]}

Garcia, C ^{[1
]}

Moreira, S ^{[1
]}

Olsen, N ^{[1
]}

Silva, HT ^{[1
]}

Pestana, OM ^{[1
]}

机构：

[1] Univ Fed Sao Paulo, Hosp Rim & Hipertensao, BR-04038002 Sao Paulo, Brazil

来源：

TRANSPLANTATION PROCEEDINGS | 2001年 / 33卷 / 1-2期

关键词：

D O I：

10.1016/S0041-1345(00)02432-5

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：1095 / 1096

页数：2

共 17 条

[1] Racial variation in dosage requirements of tacrolimus [J].

Andrews, PA ;

Sen, M ;

Chang, RWS .

LANCET, 1996, 348 (9039) :1446-1446

[2]

HARIHARAN S, 1993, CLIN TRANSPLANT, V7, P235

[3] Racial disparities in renal transplant outcomes [J].

Isaacs, RB ;

Nock, SL ;

Spencer, CE ;

Conners, AF ;

Wang, XQ ;

Sawyer, R ;

Lobo, PI .

AMERICAN JOURNAL OF KIDNEY DISEASES, 1999, 34 (04) :706-712

[4] Sirolimus reduces the incidence of acute rejection episodes despite lower cyclosporine doses in Caucasian recipients of mismatched primary renal allografts: A phase II trial [J].

Kahan, BD ;

Julian, BA ;

Pescovitz, MD ;

Vanrenterghem, Y ;

Neylan, J .

TRANSPLANTATION, 1999, 68 (10) :1526-1532

[5] Kinetic-dynamic correlations of sirolimus and cyclosporine in 438 primary renal transplant recipients [J].

Kahan, BD ;

Zimmerman, J ;

Scarola, J ;

Maida, B ;

Camardo, J .

TRANSPLANTATION, 1999, 67 (09) :S546-S546

[6] Variable oral absorption of cyclosporine - A biopharmaceutical risk factor for chronic renal, allograft rejection [J].

Kahan, BD ;

Welsh, M ;

Schoenberg, L ;

Rutzky, LP ;

Katz, SM ;

Urbauer, DL ;

VanBuren, CT .

TRANSPLANTATION, 1996, 62 (05) :599-606

[7] INFLUENCE OF CYCLOSPORINE PHARMACOKINETICS, TROUGH CONCENTRATIONS, AND AUC MONITORING ON OUTCOME AFTER KIDNEY-TRANSPLANTATION [J].

LINDHOLM, A ;

KAHAN, BD .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1993, 54 (02) :205-218

[8] Role of intestinal P-glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporine [J].

Lown, KS ;

Mayo, RR ;

Leichtman, AB ;

Hsiao, HL ;

Turgeon, DK ;

SchmiedlinRen, P ;

Brown, MB ;

Guo, WS ;

Rossi, SJ ;

Benet, LZ ;

Watkins, PB .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1997, 62 (03) :248-260

[9] Clinical pharmacokinetics and therapeutic drug monitoring of sirolimus [J].

MacDonald, A ;

Scarola, J ;

Burke, JT ;

Zimmerman, JJ .

CLINICAL THERAPEUTICS, 2000, 22 :B101-B121

[10] Combination therapy with tacrolimus and mycophenolate mofetil following cardiac transplantation: Importance of mycophenolic acid therapeutic drug monitoring [J].

Meiser, BM ;

Pfeiffer, M ;

Schmidt, D ;

Reichenspurner, H ;

Ueberfuhr, P ;

Paulus, D ;

von Scheidt, W ;

Kreuzer, E ;

Seidel, D ;

Reichart, B .

JOURNAL OF HEART AND LUNG TRANSPLANTATION, 1999, 18 (02) :143-149

← 1 2 →